ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Liabilities | ₹7,550 Cr | ₹1,309 Cr | ₹2,009 Cr | ₹2,442 Cr |
What is the latest Total Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹7,550 Cr |
| Mar2024 | ₹1,309 Cr |
| Mar2023 | ₹2,009 Cr |
| Mar2022 | ₹2,442 Cr |
How is Total Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,550 Cr | 476.97 | |
| Mar2024 | ₹1,309 Cr | -34.86 | |
| Mar2023 | ₹2,009 Cr | -17.75 | |
| Mar2022 | ₹2,442 Cr | - | |
Compare Total Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹17,404.0 Cr | -3.6% | -14.3% | -16.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -3.6% |
-14.3% |
-16.4% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses